Strategic partnerships Exactis Innovation collaborates with national hospital networks and is a trusted partner for CADTH PMDE programs, presenting a clear path for co-marketing and joint RWE studies with healthcare institutions and drug developers seeking Canadian real-world evidence.

Data-driven value The focus on high-quality data and timely real-world insights positions Exactis to offer analytics services, data curation, and decision-support tools to oncologists, payers, and life sciences companies aiming to improve treatment decisions and patient outcomes.

Collaborative opportunities Longstanding collaborations with pharma and biotech partners since 2018 indicate ample room to sell proteomic and immunotherapy guidance capabilities, potentially expanding to multimodal data offerings with partners like Sophia Genetics.

Niche market fit As a small non-profit with a pan-Canadian network, Exactis can be a cost-effective gateway for smaller biotechs and regional hospitals to access Canada-focused RWE, facilitating market entry and post-market surveillance activities.

Growth signals Recent high-level partnerships and a leadership transition signal potential for scale; sales motion can emphasize expansion of services to add-on RWE studies, proteomic profiling, and expansion into additional cancer indications across Canada.